NOUV Male Enhancement Supplement Azul Instant(TM) Now Available on Amazon
FORT LAUDERDALE, Fla., Aug. 7, 2012 /PRNewswire/ — Nouveau Life Pharmaceuticals, Inc. (Pink Sheets: NOUV), a provider of quality all-natural dietary supplements, announced today that the Company’s male enhancement supplement Azul Instant(TM) is now available for purchase on Amazon.
Azul Instant(TM) is a doctor-recommended, all-natural male enhancement supplement formulated to help men who suffer from erectile dysfunction (ED). The supplement helps to improve sexual stamina, endurance, strength, and energy. Azul Instant(TM) works in as little as 5 minutes, lasts up to 48 hours and has no side effects.*
“We plan to leverage multiple sales channels – Amazon being one of them – as part of our growth strategy,” stated Nouveau Life CEO Melissa Walker. “Amazon is a well-established, trusted online marketplace that provides us a ready-made audience of over 100 million unique visitors in Q1 alone – of course we’re going to use its service as a part of our multi-faceted sales and marketing plan.”
Azul Instant(TM) can be purchased on Amazon by visiting www.amazon.com/gp/product/B008R19QRC. As a special offer, Nouveau Life is offering free standard shipping within the United States on all orders of 2 or more 5-packs of Azul Instant(TM) placed on Amazon now through August 20, 2012. Just use coupon code SHIPAZUL at checkout to take advantage of this offer. And as always, Nouveau Life’s entire line of dietary supplements can be purchased by visiting www.nlpnaturals.com.
*Disclaimer: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements – This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.
Nouveau Life Pharmaceuticals, Inc. – 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.